MARKSANS PHARMA: Q1 CONS NET PROFIT 626M RUPEES VS 493M (YOY); 795M (QOQ)
MARKSANS PHARMA: Q1 REVENUE 3.49B RUPEES VS 3.3B (YOY); 3.3B (QOQ)
MARKSANS PHARMA:Q1 EBITDA RUPEES 774M VS 700M (YOY); 953M (QOQ) || Q1 EBITDA MARGIN 22.2% VS 21.14% (YOY); 28.88% (QOQ)